𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CA 125 in the serum and tissue of patients with gynecological disease

✍ Scribed by L. C. Fuith; G. Daxenbichler; O. Dapunt

Publisher
Springer
Year
1987
Tongue
English
Weight
382 KB
Volume
241
Category
Article
ISSN
0003-9128

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum CA 125 concentrations in patients
Serum CA 125 concentrations in patients with benign ovarian tumours
✍ Dr. Paul K. Buamah; Andrew W. Skillen πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 311 KB

Serum CA 125 concentrations have been measured in 115 patients with histologically confirmed nonmalignant pelvic disease, that is, serous cystadenoma (n = 56), mucinous cystadenoma (n = 14), fibroma (n = 33), thecoma (n = 8), and Brenner tumour (n = 4). Increased CA 125 concentrations (>35 KU/L) wer

Association between serum levels of solu
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy : A Gynecologic Oncology Group study
✍ Robert A. Burger; Kathleen M. Darcy; Philip J. DiSaia; Bradley J. Monk; Elizabet πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 1 views

## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFR‐I) and II (sTNFR‐II), alone or in combination with CA 125, were associated with clinicopathologic characteristics